File:VPRIV.jpg

From Bioinformatikpedia
Revision as of 01:09, 22 April 2012 by Zhangg (talk | contribs) (The European Commission has granted Shire marketing authorization for VPRIV® (velaglucerase alfa) for the treatment of type 1 Gaucher disease. This enzyme replacement therapy (ERT) is derived from a human cell line and has been given orphan drug status t)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
VPRIV.jpg(297 × 337 pixels, file size: 28 KB, MIME type: image/jpeg)

The European Commission has granted Shire marketing authorization for VPRIV® (velaglucerase alfa) for the treatment of type 1 Gaucher disease. This enzyme replacement therapy (ERT) is derived from a human cell line and has been given orphan drug status through the centralized procedure, making it available in 30 countries across Europe.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current01:09, 22 April 2012Thumbnail for version as of 01:09, 22 April 2012297 × 337 (28 KB)Zhangg (talk | contribs)The European Commission has granted Shire marketing authorization for VPRIV® (velaglucerase alfa) for the treatment of type 1 Gaucher disease. This enzyme replacement therapy (ERT) is derived from a human cell line and has been given orphan drug status t
  • You cannot overwrite this file.

The following page links to this file: